FundedIQ
Biotechnology

PanTheryx: Funding, Investors & Team (Oct 2026)

PanTheryx is a company based in Boulder, Colorado that specializes in medical nutrition. The company focuses on researching, developing, and selling products that improve intestinal health. They have a proprietary technology platform that they use to create their products, and they conduct clinical testing to further advance their research. PanTheryx's products are designed to meet the specific dietary needs of children with infectious diarrhea while also supporting overall intestinal health. The company's medical nutrition products fall under three FDA categories: medical foods, food for special dietary use, and dietary supplements. PanTheryx was established in 2007 by Mark A. Braman.

www.pantheryx.com LinkedIn Boulder, United States 51-100 employees
Biotechnology Dietary Supplements Health Care Medical Nutrition Pharmaceutical B2B
Total raised
$52.3M
Rounds
1
Latest
Undisclosed round
Oct 2023

PanTheryx has raised $52.3M across 1 funding round on record, the most recent an undisclosed round of $52.3M announced in Oct 2023.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

PanTheryx Company Profile and Key Stats

Total funding raised
$52.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$52.3M in Oct 2023
Employees
51-100
reported band
Headquarters
Boulder, United States

Latest funding round on record: Oct 2023.

PanTheryx Funding Rounds

Date
Round
Amount
Undisclosed round
$52.3M

PanTheryx Founders and Leadership Team

Name
Role
Contact
Bimla Starzl
Founder
—

No contact details are on record for this team yet.

PanTheryx Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

PanTheryx's latest round of $52.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like PanTheryx in Biotechnology and Boulder

Companies Similar to PanTheryx

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

PanTheryx Funding FAQs

What does PanTheryx do?

PanTheryx is a company based in Boulder, Colorado that specializes in medical nutrition. The company focuses on researching, developing, and selling products that improve intestinal health. They have a proprietary technology platform that they use to create their products, and they conduct clinical testing to further advance their research. PanTheryx's products are designed to meet the specific dietary needs of children with infectious diarrhea while also supporting overall intestinal health. The company's medical nutrition products fall under three FDA categories: medical foods, food for special dietary use, and dietary supplements. PanTheryx was established in 2007 by Mark A. Braman.

How much funding has PanTheryx raised?

PanTheryx has raised $52.3M across 1 round on record. The most recent is an undisclosed round of $52.3M announced in Oct 2023.

When did PanTheryx last raise funding?

PanTheryx's most recent funding round on record is an undisclosed round of $52.3M, announced in Oct 2023.

Who founded PanTheryx?

FundedIQ lists Bimla Starzl (Founder) at PanTheryx.

Where is PanTheryx headquartered?

PanTheryx is based in Boulder, Colorado, United States.

How many employees does PanTheryx have?

PanTheryx is in the 51-100 employee band.

How does PanTheryx's funding compare to other Biotechnology startups?

PanTheryx's latest round of $52.3M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's PanTheryx Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PanTheryx is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.